Literature DB >> 26630946

Cone-beam CT-guided radiotherapy in the management of lung cancer: Diagnostic and therapeutic value.

Khaled Elsayad1, Jan Kriz1, Gabriele Reinartz1, Sergiu Scobioala1, Iris Ernst1, Uwe Haverkamp1, Hans Theodor Eich2.   

Abstract

BACKGROUND: Recent studies have demonstrated an increase in the necessity of adaptive planning over the course of lung cancer radiation therapy (RT) treatment. In this study, we evaluated intrathoracic changes detected by cone-beam CT (CBCT) in lung cancer patients during RT. METHODS AND MATERIALS: A total of 71 lung cancer patients treated with fractionated CBCT-guided RT were evaluated. Intrathoracic changes and plan adaptation priority (AP) scores were compared between small cell lung cancer (SCLC, n = 13) and non-small cell lung cancer (NSCLC, n = 58) patients.
RESULTS: The median cumulative radiation dose administered was 54 Gy (range 30-72 Gy) and the median fraction dose was 1.8 Gy (range 1.8-3.0 Gy). All patients were subjected to a CBCT scan at least weekly (range 1-5/week). We observed intrathoracic changes in 83 % of the patients over the course of RT [58 % (41/71) regression, 17 % (12/71) progression, 20 % (14/71) atelectasis, 25 % (18/71) pleural effusion, 13 % (9/71) infiltrative changes, and 10 % (7/71) anatomical shift]. Nearly half, 45 % (32/71), of the patients had one intrathoracic soft tissue change, 22.5 % (16/71) had two, and three or more changes were observed in 15.5 % (11/71) of the patients. Plan modifications were performed in 60 % (43/71) of the patients. Visual volume reduction did correlate with the number of CBCT scans acquired (r = 0.313, p = 0.046) and with the timing of chemotherapy administration (r = 0.385, p = 0.013).
CONCLUSION: Weekly CBCT monitoring provides an adaptation advantage in patients with lung cancer. In this study, the monitoring allowed for plan adaptations due to tumor volume changes and to other anatomical changes.

Entities:  

Keywords:  Chemoradiotherapy; Intensity-modulated radiation therapy; Lung neoplasms; Radiotherapy planning, computer-assisted; Radiotherapy, image-guided

Mesh:

Year:  2015        PMID: 26630946     DOI: 10.1007/s00066-015-0927-y

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  30 in total

1.  Quantification of tumor volume changes during radiotherapy for non-small-cell lung cancer.

Authors:  Jana Fox; Eric Ford; Kristin Redmond; Jessica Zhou; John Wong; Danny Y Song
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-11-27       Impact factor: 7.038

2.  Intra thoracic anatomical changes in lung cancer patients during the course of radiotherapy.

Authors:  Margriet Kwint; Sanne Conijn; Eva Schaake; Joost Knegjens; Maddalena Rossi; Peter Remeijer; Jan-Jakob Sonke; Jose Belderbos
Journal:  Radiother Oncol       Date:  2014-11-06       Impact factor: 6.280

3.  Combining advanced radiotherapy technologies to maximize safety and tumor control probability in stage III non-small cell lung cancer.

Authors:  M Guckenberger; A Kavanagh; M Partridge
Journal:  Strahlenther Onkol       Date:  2012-08-31       Impact factor: 3.621

4.  Intra-patient variability of tumor volume and tumor motion during conventionally fractionated radiotherapy for locally advanced non-small-cell lung cancer: a prospective clinical study.

Authors:  Geert Bosmans; Angela van Baardwijk; André Dekker; Michel Ollers; Liesbeth Boersma; André Minken; Philippe Lambin; Dirk De Ruysscher
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-11-01       Impact factor: 7.038

5.  Tumor volume changes on serial imaging with megavoltage CT for non-small-cell lung cancer during intensity-modulated radiotherapy: how reliable, consistent, and meaningful is the effect?

Authors:  Malika L Siker; Wolfgang A Tomé; Minesh P Mehta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-07-12       Impact factor: 7.038

Review 6.  Adaptive radiotherapy for lung cancer.

Authors:  Jan-Jakob Sonke; José Belderbos
Journal:  Semin Radiat Oncol       Date:  2010-04       Impact factor: 5.934

7.  Potential of adaptive radiotherapy to escalate the radiation dose in combined radiochemotherapy for locally advanced non-small cell lung cancer.

Authors:  Matthias Guckenberger; Juergen Wilbert; Anne Richter; Kurt Baier; Michael Flentje
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-08-12       Impact factor: 7.038

8.  Definitive radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline.

Authors:  George Rodrigues; Hak Choy; Jeffrey Bradley; Kenneth E Rosenzweig; Jeffrey Bogart; Walter J Curran; Elizabeth Gore; Corey Langer; Alexander V Louie; Stephen Lutz; Mitchell Machtay; Varun Puri; Maria Werner-Wasik; Gregory M M Videtic
Journal:  Pract Radiat Oncol       Date:  2015 May-Jun

9.  Adaptive radiotherapy for locally advanced non-small-cell lung cancer does not underdose the microscopic disease and has the potential to increase tumor control.

Authors:  Matthias Guckenberger; Anne Richter; Juergen Wilbert; Michael Flentje; Mike Partridge
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-04-15       Impact factor: 7.038

10.  The effect of tumor volume and its change on survival in stage III non-small cell lung cancer treated with definitive concurrent chemoradiotherapy.

Authors:  Tae Ryool Koo; Sung Ho Moon; Yu Jin Lim; Ja Young Kim; Yeonjoo Kim; Tae Hyun Kim; Kwan Ho Cho; Ji-Youn Han; Young Joo Lee; Tak Yun; Heung Tae Kim; Jin Soo Lee
Journal:  Radiat Oncol       Date:  2014-12-13       Impact factor: 3.481

View more
  17 in total

Review 1.  Cardiac toxicity of lung cancer radiotherapy.

Authors:  Radovan Vojtíšek
Journal:  Rep Pract Oncol Radiother       Date:  2019-11-14

2.  Potential for adaptive dose escalation in radiotherapy for patients with locally advanced non-small-cell lung cancer in a low mid income setting.

Authors:  Sushma Agrawal; Sunil Kumar; Anil K Maurya
Journal:  Br J Radiol       Date:  2017-01-03       Impact factor: 3.039

Review 3.  Predictive and prognostic value of tumor volume and its changes during radical radiotherapy of stage III non-small cell lung cancer : A systematic review.

Authors:  Lukas Käsmann; Maximilian Niyazi; Oliver Blanck; Christian Baues; René Baumann; Sophie Dobiasch; Chukwuka Eze; Daniel Fleischmann; Tobias Gauer; Frank A Giordano; Yvonne Goy; Jan Hausmann; Christoph Henkenberens; David Kaul; Lisa Klook; David Krug; Matthias Mäurer; Cédric M Panje; Johannes Rosenbrock; Lisa Sautter; Daniela Schmitt; Christoph Süß; Alexander H Thieme; Maike Trommer-Nestler; Sonia Ziegler; Nadja Ebert; Daniel Medenwald; Christian Ostheimer
Journal:  Strahlenther Onkol       Date:  2017-10-13       Impact factor: 3.621

4.  Is tumor volume reduction during radiotherapy prognostic relevant in patients with stage III non-small cell lung cancer?

Authors:  Khaled Elsayad; Laith Samhouri; Sergiu Scobioala; Uwe Haverkamp; Hans Theodor Eich
Journal:  J Cancer Res Clin Oncol       Date:  2018-04-05       Impact factor: 4.553

5.  On the evaluation of mobile target trajectory between four-dimensional computer tomography and four-dimensional cone-beam computer tomography.

Authors:  Colton Baley; Neil Kirby; Timothy Wagner; Nikos Papanikolaou; Pamela Myers; Karl Rasmussen; Sotirios Stathakis; Daniel Saenz
Journal:  J Appl Clin Med Phys       Date:  2021-06-03       Impact factor: 2.102

6.  Multitask 3D CBCT-to-CT translation and organs-at-risk segmentation using physics-based data augmentation.

Authors:  Navdeep Dahiya; Sadegh R Alam; Pengpeng Zhang; Si-Yuan Zhang; Tianfang Li; Anthony Yezzi; Saad Nadeem
Journal:  Med Phys       Date:  2021-08-09       Impact factor: 4.506

7.  Motion monitoring during a course of lung radiotherapy with anchored electromagnetic transponders : Quantification of inter- and intrafraction motion and variability of relative transponder positions.

Authors:  Daniela Schmitt; Simeon Nill; Falk Roeder; Daniela Gompelmann; Felix Herth; Uwe Oelfke
Journal:  Strahlenther Onkol       Date:  2017-07-21       Impact factor: 3.621

8.  Image-guidance triggered adaptive replanning of radiation therapy for locally advanced lung cancer: an evaluation of cases requiring plan adaptation.

Authors:  Sarit Appel; Jair Bar; Dror Alezra; Maoz Ben-Ayun; Tatiana Rabin-Alezra; Nir Honig; Tamar Katzman; Sumit Chatterji; Zvi Symon; Yaacov Richard Lawrence
Journal:  Br J Radiol       Date:  2019-11-13       Impact factor: 3.039

9.  Improved adaptive radiotherapy to adjust for anatomical alterations during curative treatment for locally advanced lung cancer.

Authors:  Maria Moksnes Bjaanæs; Erlend Peter Skaug Sande; Øyvind Loe; Christina Ramberg; Tove Mette Næss; Andreas Ottestad; Lotte V Rogg; Jørund Graadal Svestad; Vilde Drageset Haakensen
Journal:  Phys Imaging Radiat Oncol       Date:  2021-05-08

10.  Effect of image-guided hypofractionated stereotactic radiotherapy on peripheral non-small-cell lung cancer.

Authors:  Shu-Wen Wang; Juan Ren; Yan-Li Yan; Chao-Fan Xue; Li Tan; Xiao-Wei Ma
Journal:  Onco Targets Ther       Date:  2016-08-16       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.